Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery
The DOI matches its Crossref record; 443 of the 443 references it cites were found in a registry or an index.
Abstract
Design and functionalization strategies for multifunctional nanocarriers (e.g., nanoparticles, micelles, polymersomes) based on biodegradable/biocompatible polymers intended to be employed for active targeting and drug delivery are reviewed. This review will focus on the nature of the polymers involved in the preparation of targeted nanocarriers, the synthesis methods to achieve the desired macromolecular architecture, the selected coupling strategy, the choice of the homing molecules (vitamins, hormones, peptides, proteins, etc.), as well as the various strategies to display them at the surface of nanocarriers. The resulting morphologies and the main colloidal features will be given as well as an overview of the biological activities, with a special focus on the main in vivo achievements.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Today, PLA resin has been approved by the FDA and European regulatory authorities for use in food- and drug-delivery systems [12,34].”
From Synthesis and Biological Application of Polylactic Acid (2020) · cites this paper as [34]
Citations
Cites
In vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008) · Chemical Reviews · doi:10.1021/cr068445e · Cited by 6,852
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
The golden age: gold nanoparticles for biomedicine
Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., & El-Sayed, M. A. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15237h · Cited by 3,550
Biodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191
Research works printed but not linked: 24
- Erb, 2009, Drug Delivery Syst., 24, 63
- Marty, 1978, Pharm. Acta Helv., 53, 17
- Gabizon, 1994, Cancer Res., 54, 987
- Goren, 2000, Clin. Cancer Res., 6, 1949
- Ross, 1994, Cancer, 73, 2432, 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S · DOI · Paper page
- Eliaz, 2001, Cancer Res., 61, 2592
- Damjanov, 1987, Lab. Invest., 57, 5
- Casy, 1988, J. Clin. Pharmacol., 28, 191
- Beketic-Oreskovic, 1993, Neoplasma, 40, 69
- Ona, 1973, Cancer, 31, 324, 10.1002/1097-0142(197302)31:2<324::AID-CNCR2820310208>3.0.CO;2-Y · doi:10.1002/1097-0142(197302)31:2<324::aid-cncr2820310208>3.0.co;2-y
- Peipp, 2002, Cancer Res., 62, 2848
- Lupold, 2002, Cancer Res., 62, 4029
- Moro, 1997, Cancer Res., 57, 1922
- Nie, 2009, J. Mater. Sci.: Mater. Med., 20, 1849
- Liu, 2010, J. Mater. Sci.: Mater. Med., 21, 551
- Yousefpour, 2011, Int. J. Nanomed., 6, 1977
- Sahu, 2010, J. Mater. Sci.: Mater. Med., 21, 1587
- Taheri, 2011, Int. J. Nanomed., 6, 1863
- Tian, 2012, Int. J. Nanomed., 7, 1031
- Nicolas, 2009, Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol., 1, 111
- Harper, 1999, Clin. Cancer Res., 5, 4242
- Armstrong, 1994, Cancer Res., 54, 5280
- Kamer, 2004, Int. J. Mol. Med., 13, 143
- Colle, 1988, Curr. Ther. Res. Clin. E, 44, 1045
Cited by
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy
Chen, G., Roy, I., Yang, C., & Prasad, P. N. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00148 · Cited by 1,499
Polymeric Nanoparticles for Drug Delivery
Beach, M. A., Nayanathara, U., Gao, Y., Zhang, C., Xiong, Y., Wang, Y., & Such, G. K. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00705 · Cited by 1,155
Nanomaterials for cancer therapy: current progress and perspectives
Cheng, Z., Li, M., Dey, R., & Chen, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01096-0 · Cited by 1,168
Metadata
- Authors
- Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Nicolas, Julien
- Venue
- Chem. Soc. Rev.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 42
- Issue
- 3
- Pages
- 1147-1235
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2027432937
- Cited by
- 1,270
- References
- 443
- Citations by year
- 2026: 25 · 2025: 46 · 2024: 61 · 2023: 78 · 2022: 75 · 2021: 85 · 2020: 90 · 2019: 125 · 2018: 131 · 2017: 136 · 2016: 140 · 2015: 121 · 2014: 102 · 2013: 54
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Chemical Society Reviews (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- targeted drug delivery, biodegradable polymers, biocompatible polymers, nanocarriers, active targeting, polymersomes, micelles, nanoparticles, peptide conjugation, protein conjugation, surface functionalization, macromolecular architecture, colloidal properties, in vivo biodistribution
- MeSH terms
- Biocompatible Materials, Drug Carriers, Humans, Micelles, Models, Molecular, Polymers, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.